March 2021 highlights from AJPH
Highlights from the AJPH March 2021 Issue.
Read morenews, journals and articles from all over the world.
Highlights from the AJPH March 2021 Issue.
Read moreAerosolized Hydrogen Peroxide Decontaminator is among the 11 outstanding New Normal lifestyle innovations chosen by the Ministry of Higher Education, Science, Research and Innovation.
Read moreThe National Comprehensive Cancer Network put out new guidance for COVID-19 vaccinations in people with cancer, based on available evidence plus consensus from top hematology and oncology experts with particular expertise in infectious diseases, vaccine development and delivery, and medical ethics.
Read moreA new online platform to help mobilize volunteer health care professionals to treat patients during COVID-19 has officially launched, just as the number of cases, hospitalizations and deaths are increasing across the country. Provider Bridge (ProviderBridge.org), supports license portability by making it easier to connect volunteer health care professionals with state agencies and health care entities in order to quickly increase access to care for patients in rural and underserved communities.
Read moreNew research into opioid overdoses that occurred during the COVID-19 pandemic highlighted new disparities along racial lines that are likely fueled by existing inequality
Read moreDeveloped by a research team led by Maurizio Porfiri, Institute Professor at the NYU Tandon School of Engineering, a novel open-source platform comprises an agent-based model (ABM) of COVID-19 for the entire town of New Rochelle, in Westchester County, New York State.
Read moreResearchers at Washington University School of Medicine in St. Louis have found that patients with Barrett’s esophagus may be vulnerable to coronavirus infection from what they swallow.
Read moreA new therapy developed by researchers at Rush University Medical Center is showing success as a way to prevent COVID-19 symptoms in mice.
Read moreScientists at Washington University School of Medicine in St. Louis have shown that a relatively simple and rapid blood test can predict which patients with COVID-19 are at highest risk of severe complications or death. The blood test measures levels of mitochondrial DNA, which normally resides inside the energy factories of cells. Mitochondrial DNA spilling out of cells and into the bloodstream is a sign that a particular type of violent cell death is taking place in the body.
Israel’s Technion will award an honorary doctorate to Pfizer CEO and Chairman Dr. Albert Bourla, for leading the development of the novel vaccine against SARS-CoV-2, the virus that causes COVID-19. The honorary doctorate will be conferred at the Technion Board of Governors meeting in November 2021.
Read moreResearchers at the University of Wisconsin School of Medicine and Public Health and UW Health have developed a tool that incorporates a person’s age and socioeconomic status to prioritize vaccine distribution among people who otherwise share similar risks due to their jobs.
Read moreA new Houston Methodist study found males are more likely to test positive for COVID-19, have complications and die from the virus than females, independent of age. The peer-reviewed observational study appears in PLOS ONE, a multidisciplinary journal published by the Public Library of Science.
Read more